PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer

Clinical trial NCT04360941 · RECRUITING

Trial details

NCT number: NCT04360941
Sponsor: Royal Marsden NHS Foundation Trust
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Triple Negative Breast Cancer Locally Advanced Breast Cancer Recurrent Breast Cancer Metastatic Breast Cancer ER+ Breast Cancer HER2-positive Breast Cancer

Start date: 2020-08-11
Primary completion: 2027-07-31
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.